UNSPSC 51143301: Phenobarbital/phenytoin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN400. This VA Drug Class (CN400) classifies this compound as belonging to the group ANTICONVULSANTS.

UNSPSC 51143301 Phenobarbital/phenytoin is a Commodity code that nominally covers anticonvulsant pharmaceuticals, but the recent state and local procurement activity tagged under this code does not reflect that scope. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026, seeks naloxone and safe drug deactivation systems—opioid-reversal agents and harm-reduction equipment—not anticonvulsant drugs. This mismatch suggests either a cataloging error in the county's procurement system or a broader tagging practice that does not align the code to the actual commodity being purchased. The code shows minimal recent state and local activity relevant to its nominal pharmaceutical scope.

The single recent opportunity under this code is Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county requires electronic bid submission through its e-Procurement Portal, unit pricing for each line item, drug-free workplace certification, and E-Verify compliance. The contract carries an initial two-year term with a one-year renewal option and a three-month probationary period allowing termination at will. Vendors must carry workers' compensation, commercial general liability, and professional liability insurance, and the procurement may draw FEMA funding, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations are noted. The geographic activity is limited to Florida based on available records.